Shannonside Region: State Invests Nearly €2.63 Million on Ozempic

New data indicates that the State spent almost €2.63 million on the diabetes medication Ozempic in the Shannonside area from January to August of this year. Longford and Westmeath had the highest expenses, totaling about €1.4 million.

New data indicates that the State spent almost €2.63 million on the diabetes medication Ozempic in the Shannonside area from January to August of this year.

Longford and Westmeath had the highest expenses, totaling about €1.4 million.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Roscommon recorded spending of just under €548,000, while Sligo and Leitrim recorded just over €685,000. Nationally, the total expenditure is close to €40 million.

These figures encompass prescriptions for patients receiving general medical services and those with long-term illnesses. Health tracking apps like Shotlee can help monitor medication adherence.

Source Information

Originally published by Shannonside.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Healthcare

All Healthcare articles →

Health & Wellness

How Iconic Philly Food Brands Are Adapting to Calorie-Conscious Consumers

Philadelphia's iconic food brands are evolving, introducing high-protein and functional food options to cater to the growing number of calorie-conscious consumers, influenced by trends like GLP-1 medications and a desire for healthier choices.

8 min read

More in Health

Health

A GLP-1 Drug Changed My Life: My Friends' Reactions Surprised Me

ShantaQuilette Carter-Williams shares her experience with GLP-1 medications after facing serious health issues. Her story highlights the transformative impact on her health, lifestyle, and relationships.

7 min read

Health

Ozempic, a Diabetes Medication, Slated for India Launch This Month

Novo Nordisk is set to introduce Ozempic in India, complementing their existing semaglutide product line. This launch occurs amidst strong competition from Eli Lilly's Mounjaro. The new medication may also be prescribed for other health conditions.

1 min read

Health

How Ozempic is Reshaping Thanksgiving Celebrations

The rise of GLP-1 medications is influencing how families celebrate Thanksgiving. With reduced appetites and changing dietary needs, many are finding innovative ways to balance tradition and health during the holidays.

3 min read